Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Phase II study of oblimersen sodium and rituximab...
Conference

Phase II study of oblimersen sodium and rituximab in patients with recurrent B-cell non-Hodgkin's lymphoma.

Authors

Pro B; Smith MR; Leber B; Younes A; Fayad L; Hagemeister FB; McLaughlin P; Rodriguez AM; Caddick Y; Zwiebel JA

Volume

23

Pagination

pp. 587S-587S

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

June 1, 2005

Name of conference

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Conference place

Orlando, FL

Conference start date

May 13, 2005

Conference end date

May 17, 2005

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

16

ISSN

0732-183X

Labels

Fields of Research (FoR)